The lack of methylation of the FMR1 FM can predict a good outcome, and more detailed FXS genetic testing (including methylation status) should be obtained for individuals diagnosed with FXS to prognosticate cognitive and behavioral outcomes. Here, FMR1 is linked to fragile X syndrome.